Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France; Department of Gastroenterology, University Hospital of Marseille Nord, University of Aix-Marseille, Marseille, France.
Clin Gastroenterol Hepatol. 2021 Sep;19(9):1899-1905.e1. doi: 10.1016/j.cgh.2021.01.028. Epub 2021 Jan 22.
BACKGROUND & AIMS: Ulcerative colitis (UC) is increasingly recognized as a progressive disease and patients with long-standing disease can develop colorectal stricture. Few data about its incidence in UC are available, while risk factors for colorectal strictures in UC remain to be determined. We assessed the incidence of and risk factors for developing colorectal strictures in a large UC population.
All adult patients followed at Nancy University hospital and at the centre hospitalier de Luxembourg for UC, between January 2004 and July 2019, were eligible for inclusion in this multicenter retrospective cohort study.
A total of 439 patients with UC were included. Median follow-up duration was 9.6 years. Incidence of colorectal stricture was 3.6%. The cumulative probability of developing this complication was 1% at 5 years and 2.3% at 10 years. Median age at stricture diagnosis was 47.9 years (41.0; 63.0), and median time from UC diagnosis to onset of stricture was 11.5 years (5; 15.3). Montreal A3 classification (age > 40 years) (P = .008) and steroids use (HR = 4.1; 95% CI, 1.1-16.1) were independent risk factors for stricture, whereas mesalamine-treated patients carried a lower risk (HR = 0.3; 95% CI, 0.1-0.9). Dysplasia was found in 6 patients with strictures (42.9%) and among them 5 developed a colorectal cancer (33.3%).
Patients with Montreal A3 classification and those exposed to steroids have a higher risk for strictures, while use of mesalamine lowers this risk. These factors should be assessed in daily clinical practice to prevent stricture occurrence in these patients.
溃疡性结肠炎(UC)被越来越多地认为是一种进展性疾病,长期患病的患者可能会发展为结直肠狭窄。关于 UC 中该病发生率的数据很少,而 UC 中结直肠狭窄的危险因素仍有待确定。我们评估了大型 UC 人群中发生结直肠狭窄的发生率和危险因素。
本多中心回顾性队列研究纳入了 2004 年 1 月至 2019 年 7 月期间在南锡大学医院和卢森堡中心医院接受治疗的所有成年 UC 患者。
共纳入 439 例 UC 患者。中位随访时间为 9.6 年。结直肠狭窄的发生率为 3.6%。该并发症的累积发生率为 5 年时 1%,10 年时 2.3%。狭窄诊断时的中位年龄为 47.9 岁(41.0;63.0),从 UC 诊断到狭窄发病的中位时间为 11.5 年(5;15.3)。40 岁以上的蒙特利尔 A3 分类(P =.008)和类固醇的使用(HR = 4.1;95%CI,1.1-16.1)是狭窄的独立危险因素,而美沙拉嗪治疗的患者风险较低(HR = 0.3;95%CI,0.1-0.9)。6 例狭窄患者(42.9%)中发现了异型增生,其中 5 例发生了结直肠癌(33.3%)。
具有蒙特利尔 A3 分类和暴露于类固醇的患者发生狭窄的风险较高,而使用美沙拉嗪可降低这种风险。在日常临床实践中应评估这些因素,以预防这些患者发生狭窄。